Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese men

International Journal of Clinical Oncology

Volumn 9, Issue 1, 2004, Pages 64-67

  Sakai, Iori ^a   Harada, Ken Ichi ^a   Hara, Isao ^b   Eto, Hiroshi ^a   Miyake, Hideaki ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Free total PSA ratio; Prostate cancer; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

HUMANS; JAPAN; LYMPH NODE EXCISION; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 1842633252     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-003-0365-1     Document Type: Article

References (13)

1. Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 162:293-306
2. Benson MC, Whang IS, Olsson CA, et al. (1992) The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147:815-816
3. Carter HB, Pearson JD, Metter EJ, et al. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267:2215-2220
4. Oesterling JE, Jacobson SJ, Klee GG, et al. (1995) Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090-1095
5. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51:222-226
6. Catalona WJ, Beiser JA, Smith DS (1997) Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 158:2162-2167
7. Masters JG, Keegan PE, Hildreth AJ, et al. (1998) Free/total serum prostate-specific antigen ratio: how helpful is it in detecting prostate cancer? Br J Urol 81:419-423
8. Melchior SW, Noteboom J, Gillitzer R, et al. (2001) The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy. BJU Int 88:221-225
9. Okihara K, Cheli CD, Partin AW, et al. (2002) Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 167:2017-2023
10. Pannek J, Rittenhouse HG, Chan DW, et al. (1998) The use of percent free prostate specific antigen for staging clinically localized prostate cancer. J Urol 159:1238-1242
11. Catalona WJ, Smith DS, Wolfert RL, et al. (1995) Elevation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-1220
12. Furuya Y, Akakura K, H ito (2000) Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer. Int J Clin Oncol 5:8-11
13. Maeda H, Arai Y, Ishitoya S, et al. (1998) Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer. Acta Urol Jpn 44:307-311